The HMG-CoA reductase inhibitor, simvastatin, has...

Gynecologic Oncology 2015 / 04 Vol. 137

The HMG-CoA reductase inhibitor, simvastatin, has anti-tumorigenic effects in ovarian cancer cell lines and a genetically engineered serous ovarian cancer mouse model

Stine, J.E., Han, X., Schointuch, M., Zhou, C., Gilliam, T., Kim, K.H., Gehrig, P.A., Bae-Jump, V.L.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
137
Language:
english
Journal:
Gynecologic Oncology
DOI:
10.1016/j.ygyno.2015.01.149
Date:
April, 2015
File:
PDF, 229 KB
english, 2015
Conversion to is in progress
Conversion to is failed